Amyloid-β oligomers regulate the properties of human neural stem cells through GSK-3β signaling

Experimental and Molecular Medicine

Volumn 45, Issue 11, 2013, Pages

  Lee, Il Shin ^a   Jung, Kwangsoo ^b   Kim, Il Sun ^a   Park, Kook In ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Amyloid oligomers; Differentiation; Glycogen synthase kinase 3 ; Human neural stem cells; Migration; Proliferation

Indexed keywords

AMYLOID BETA PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; OLIGOMER; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; CULTURE MEDIUM;

ARTICLE; CELL AGING; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; FETUS; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL MOBILIZATION; TELENCEPHALON; TELOMERE; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL MOTION; CELL STRAIN HEK293; CHEMISTRY; CYTOLOGY; DRUG EFFECT; METABOLISM; MOUSE; PHYSIOLOGY; TELOMERE SHORTENING; DRUG EFFECTS; HEK293 CELL LINE; PHARMACOLOGY;

AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; CELL AGING; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; FETUS; GLYCOGEN SYNTHASE KINASE 3; HEK293 CELLS; HUMANS; MICE; MICE, INBRED C57BL; NEURAL STEM CELLS; SIGNAL TRANSDUCTION; TELOMERE SHORTENING;

EID: 84896581682     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2013.125     Document Type: Article

References (69)

1. Breunig JJ, Haydar TF, Rakic P. Neural stem cells: Historical perspective and future prospects. Neuron 2011; 70: 614-625.
2. Kriegstein A, Alvarez-Buylla A. The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci 2009; 32: 149-184.
3. Temple S. The development of neural stem cells. Nature 2001; 414: 112-117.
4. Lindvall O, Kokaia Z. Stem cells in human neurodegenerative disorders-Time for clinical translation? J Clin Invest 2010; 120: 29-40.
5. Lee JP, Jeyakumar M, Gonzalez R, Takahashi H, Lee PJ, Baek RC et al. Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat Med 2007; 13: 439-447.
6. Tamaki SJ, Jacobs Y, Dohse M, Capela A, Cooper JD, Reitsma M et al. Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis. Cell Stem Cell 2009; 5: 310-319.
7. Andres RH, Horie N, Slikker W, Keren-Gill H, Zhan K, Sun G et al. Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain 2011; 134: 1777-1789.
8. Mine Y, Tatarishvili J, Oki K, Monni E, Kokaia Z, Lindvall O. Grafted human neural stem cells enhance several steps of endogenous neurogenesis and improve behavioral recovery after middle cerebral artery occlusion in rats. Neurobiol Dis 2013; 52: 191-203.
9. Cummings BJ, Uchida N, Tamaki SJ, Salazar DL, Hooshmand M, Summers R et al. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci USA 2005; 102: 14069-14074.
10. Pluchino S, Gritti A, Blezer E, Amadio S, Brambilla E, Borsellino G et al. Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates. Ann Neurol 2009; 66: 343-354.
11. Holtzman DM, Morris JC, Goate AM. Alzheimer's disease: The challenge of the second century. Sci Transl Med 2011; 3: 77sr71.
12. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl JMed 2010; 362: 329-344.
13. Wyss-Coray T. Inflammation in Alzheimer disease: Driving force, bystander or beneficial response? Nat Med 2006; 12: 1005-1015.
14. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CWet al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003; 300: 486-489.
15. Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL et al. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci 2004; 24: 10191-10200.
16. Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 2007; 8: 101-112.
17. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-Term potentiation in vivo. Nature 2002; 416: 535-539.
18. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 2005; 8: 79-84.
19. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 2006; 440: 352-357.
20. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 2008; 14: 837-842.
21. Reed MN, Hofmeister JJ, Jungbauer L, Welzel AT, Yu C, Sherman MA et al. Cognitive effects of cell-derived and synthetically derived Abeta oligomers. Neurobiol Aging 2011; 32: 1784-1794.
22. Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe DJ. Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci USA 2011; 108: 5819-5824.
23. He P, Shen Y. Interruption of beta-catenin signaling reduces neurogenesis in Alzheimer's disease. J Neurosci 2009; 29: 6545-6557.
24. Magdesian MH, Carvalho MM, Mendes FA, Saraiva LM, Juliano MA, Juliano L et al. Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling. J Biol Chem 2008; 283: 9359-9368.
25. Takashima A, Honda T, Yasutake K, Michel G, Murayama O, Murayama M et al. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci Res 1998; 31: 317-323.
26. Ly PT, Wu Y, Zou H, Wang R, Zhou W, Kinoshita A et al. Inhibition of GSK3beta-mediated BACE1 expression reduces Alzheimer-Associated phenotypes. J Clin Invest 2013; 123: 224-235.
27. Jin K, Galvan V, Xie L, Mao XO, Gorostiza OF, Bredesen DE et al. Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice. Proc Natl Acad Sci USA 2004; 101: 13363-13367.
28. Lopez-Toledano MA, Shelanski ML. Neurogenic effect of beta-Amyloid peptide in the development of neural stem cells. J Neurosci 2004; 24: 5439-5444.
29. Haughey NJ, Nath A, Chan SL, Borchard AC, Rao MS, Mattson MP. Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J Neurochem 2002; 83: 1509-1524.
30. Donovan MH, Yazdani U, Norris RD, Games D, German DC, Eisch AJ. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease. J Comp Neurol 2006; 495: 70-83.
31. Crews L, Adame A, Patrick C, Delaney A, Pham E, Rockenstein E et al. Increased BMP6 levels in the brains of Alzheimer's disease patients and APP transgenic mice are accompanied by impaired neurogenesis. J Neurosci 2010; 30: 12252-12262.
32. Mazur-Kolecka B, Golabek A, Nowicki K, Flory M, Frackowiak J. Amyloidbeta impairs development of neuronal progenitor cells by oxidative mechanisms. Neurobiol Aging 2006; 27: 1181-1192.
33. Eucher JN, Uemura E, Sakaguchi DS, Greenlee MH. Amyloid-beta peptide affects viability but not differentiation of embryonic and adult rat hippocampal progenitor cells. Exp Neurol 2007; 203: 486-492.
34. Chen Y, Dong C. Abeta40 promotes neuronal cell fate in neural progenitor cells. Cell Death Differ 2009; 16: 386-394.
35. Karkkainen V, Magga J, Koistinaho J, Malm T. Brain environment and Alzheimer's disease mutations affect the survival, migration and differentiation of neural progenitor cells. Curr Alzheimer Res 2012; 9: 1030-1042.
36. Jin K, Peel AL, Mao XO, Xie L, Cottrell BA, Henshall DC et al. Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci USA 2004; 101: 343-347.
37. Boekhoorn K, Joels M, Lucassen PJ. Increased proliferation reflects glial and vascular-Associated changes, but not neurogenesis in the presenile Alzheimer hippocampus. Neurobiol Dis 2006; 24: 1-14.
38. Gil ME, Coetzer TL. Real-Time quantitative PCR of telomere length. Mol Biotechnol 2004; 27: 169-172.
39. Criscuolo F, Bize P, Nasir L, Metcalfe NB, Foote CG, Griffiths K et al. Realtime quantitative PCR assay for measurement of avian telomeres. J Avian Biol 2009; 40: 342-347.
40. Hwang DY, Cho JS, Lee SH, Chae KR, Lim HJ, Min SH et al. Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw. Exp Neurol 2004; 186: 20-32.
41. Schagger H. Tricine-SDS-PAGE. Nat Protoc 2006; 1: 16-22.
42. Dahlgren KN, Manelli AM, Stine Jr WB, Baker LK, Krafft GA, LaDu MJ. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 2002; 277: 32046-32053.
43. He F, Ge W, Martinowich K, Becker-Catania S, Coskun V, Zhu W et al. A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis. Nat Neurosci 2005; 8: 616-625.
44. Bonni A, Sun Y, Nadal-Vicens M, Bhatt A, Frank DA, Rozovsky I et al. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 1997; 278: 477-483.
45. Yang TT, Hsu CT, Kuo YM. Cell-derived soluble oligomers of human amyloid-beta peptides disturb cellular homeostasis and induce apoptosis in primary hippocampal neurons. J Neural Transm 2009; 116: 1561-1569.
46. Podlisny MB, Ostaszewski BL, Squazzo SL, Koo EH, Rydell RE, Teplow DB et al. Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J Biol Chem 1995; 270: 9564-9570.
47. Lesne SE, Sherman MA, Grant M, Kuskowski M, Schneider JA, Bennett DA et al. Brain amyloid-beta oligomers in ageing and Alzheimer's disease. Brain 2013; 136: 1383-1398.
48. Mc Donald JM, Savva GM, Brayne C, Welzel AT, Forster G, Shankar GM et al. The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-Type dementia. Brain 2010; 133: 1328-1341.
49. Kim HT, Kim IS, Lee IS, Lee JP, Snyder EY, Park KI. Human neurospheres derived from the fetal central nervous system are regionally and temporally specified but are not committed. Exp Neurol 2006; 199: 222-235.
50. Park S, Kim HT, Yun S, Kim IS, Lee J, Lee IS et al. Growth factorexpressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice. Exp Mol Med 2009; 41: 487-500.
51. Lee HK, Kumar P, Fu Q, Rosen KM, Querfurth HW. The insulin/Akt signaling pathway is targeted by intracellular beta-Amyloid. Mol Biol Cell 2009; 20: 1533-1544.
52. Chenn A, Walsh CA. Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 2002; 297: 365-369.
53. Donnini S, Solito R, Cetti E, Corti F, Giachetti A, Carra S et al. Abeta peptides accelerate the senescence of endothelial cells in vitro and in vivo, impairing angiogenesis. FASEB J 2010; 24: 2385-2395.
54. Damjanovic AK, Yang Y, Glaser R, Kiecolt-Glaser JK, Nguyen H, Laskowski B et al. Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients. J Immunol 2007; 179: 4249-4254.
55. Ross HH, Levkoff LH, Marshall GP 2nd, Caldeira M, Steindler DA, Reynolds BA et al. Bromodeoxyuridine induces senescence in neural stem and progenitor cells. Stem Cells 2008; 26: 3218-3227.
56. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature 2004; 430: 631-639.
57. Nakatomi H, Kuriu T, Okabe S, Yamamoto S, Hatano O, Kawahara N et al. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 2002; 110: 429-441.
58. Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003; 302: 1760-1765.
59. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci USA 2004; 101: 18117-18122.
60. Ming GL, Song H. Adult neurogenesis in the mammalian brain: Significant answers and significant questions. Neuron 2011; 70: 687-702.
61. Lie DC, Colamarino SA, Song HJ, Desire L, Mira H, Consiglio A et al. Wnt signalling regulates adult hippocampal neurogenesis. Nature 2005; 437: 1370-1375.
62. Hirabayashi Y, Itoh Y, Tabata H, Nakajima K, Akiyama T, Masuyama N et al. The Wnt/beta-catenin pathway directs neuronal differentiation of cortical neural precursor cells. Development 2004; 131: 2791-2801.
63. Munji RN, Choe Y, Li G, Siegenthaler JA, Pleasure SJ. Wnt signaling regulates neuronal differentiation of cortical intermediate progenitors. J Neurosci 2011; 31: 1676-1687.
64. Caricasole A, Copani A, Caraci F, Aronica E, Rozemuller AJ, Caruso A et al. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain. J Neurosci 2004; 24: 6021-6027.
65. Beurel E, Jope RS. Differential regulation of STAT family members by glycogen synthase kinase-3. J Biol Chem 2008; 283: 21934-21944.
66. Zhu Z, Kremer P, Tadmori I, Ren Y, Sun D, He X et al. Lithium suppresses astrogliogenesis by neural stem and progenitor cells by inhibiting STAT3 pathway independently of glycogen synthase kinase 3 beta. PLoS One 2011; 6: E23341.
67. Wan J, Fu AK, Ip FC, Ng HK, Hugon J, Page G et al. Tyk2/STAT3 signaling mediates beta-Amyloid-induced neuronal cell death: Implications in Alzheimer's disease. J Neurosci 2010; 30: 6873-6881.
68. Yokota Y, Eom TY, Stanco A, Kim WY, Rao S, Snider WD et al. Cdc42 and Gsk3 modulate the dynamics of radial glial growth, inter-radial glial interactions and polarity in the developing cerebral cortex. Development 2010; 137: 4101-4110.
69. Asada N, Sanada K. LKB1-mediated spatial control of GSK3beta and adenomatous polyposis coli contributes to centrosomal forward movement and neuronal migration in the developing neocortex. J Neurosci 2010; 30: 8852-8865.